These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25565373)

  • 1. Pharmacoinformatics analysis to identify inhibitors of Mtb-ASADH.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2016; 34(1):1-14. PubMed ID: 25565373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of ternary complexes of aspartate-semialdehyde dehydrogenase (Rv3708c) from Mycobacterium tuberculosis H37Rv.
    Vyas R; Tewari R; Weiss MS; Karthikeyan S
    Acta Crystallogr D Biol Crystallogr; 2012 Jun; 68(Pt 6):671-9. PubMed ID: 22683789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMB-XMA0038, a new inhibitor targeting aspartate-semialdehyde dehydrogenase of
    Wang X; Yang R; Liu S; Guan Y; Xiao C; Li C; Meng J; Pang Y; Liu Y
    Emerg Microbes Infect; 2021 Dec; 10(1):2291-2299. PubMed ID: 34779708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening.
    Saxena S; Devi PB; Soni V; Yogeeswari P; Sriram D
    J Mol Graph Model; 2014 Feb; 47():37-43. PubMed ID: 24316937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural-functional analysis of drug target aspartate semialdehyde dehydrogenase.
    Kumar R; R R; Diwakar V; Khan N; Kumar Meghwanshi G; Garg P
    Drug Discov Today; 2024 Mar; 29(3):103908. PubMed ID: 38301800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of Aspartic Acid Semialdehyde Dehydrogenase as a New Anti-Mycobacterium Tuberculosis Target.
    Meng J; Yang Y; Xiao C; Guan Y; Hao X; Deng Q; Lu Z
    Int J Mol Sci; 2015 Sep; 16(10):23572-86. PubMed ID: 26437401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into inhibitor binding to a fungal ortholog of aspartate semialdehyde dehydrogenase.
    Dahal GP; Viola RE
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2848-2854. PubMed ID: 30107909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies.
    Maganti L; Grandhi P; Ghoshal N
    J Mol Graph Model; 2016 Nov; 70():14-22. PubMed ID: 27639087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sengupta S; Roy D; Bandyopadhyay S
    J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elaboration of a fragment library hit produces potent and selective aspartate semialdehyde dehydrogenase inhibitors.
    Thangavelu B; Bhansali P; Viola RE
    Bioorg Med Chem; 2015 Oct; 23(20):6622-31. PubMed ID: 26404410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
    J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural comparison of Mtb-DHFR and h-DHFR for design, synthesis and evaluation of selective non-pteridine analogues as antitubercular agents.
    Sharma K; Tanwar O; Sharma S; Ali S; Alam MM; Zaman MS; Akhter M
    Bioorg Chem; 2018 Oct; 80():319-333. PubMed ID: 29986181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modelling and comparative structural account of aspartyl beta-semialdehyde dehydrogenase of Mycobacterium tuberculosis (H37Rv).
    Singh A; Kushwaha HR; Sharma P
    J Mol Model; 2008 Apr; 14(4):249-63. PubMed ID: 18236087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and enzymatic evaluation to identify selective inhibitors of aspartate semialdehyde dehydrogenase.
    Luniwal A; Wang L; Pavlovsky A; Erhardt PW; Viola RE
    Bioorg Med Chem; 2012 May; 20(9):2950-6. PubMed ID: 22464683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capture of an intermediate in the catalytic cycle of L-aspartate-beta-semialdehyde dehydrogenase.
    Blanco J; Moore RA; Viola RE
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12613-7. PubMed ID: 14559965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.